Skip to main content

Table 3 Treatment parameters and response

From: Clinico-epidemiological profile and treatment outcomes in patients with squamous cell carcinoma of the esophagus following docetaxel-based neoadjuvant chemotherapy: experience from a cancer care center in Northeast India

Characteristics (N = 48)

Frequency (%)

Median no. of chemotherapy cycles

3

Most common toxicities

 Grade 2 neutropenia

28 (58)

 Grade 3 anemia

6 (12)

 Grade 2 vomiting

4 (8)

 None

10 (22)

Median treatment time for NACT completion (range) in days

52 (43‑68)

Median time gap between the end of NACT and surgery (range) in days

31 (22‑44)

Treatment response

 Pathological CR (pCR)

8 (17)

 Residual disease (less than pCR)

40 (83)

R0 resection rates

 Yes

42 (88)

 No

6 (12)

2-year survival (%)

66